Cargando…

ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy

Cardiac hypertrophy is an adaptive and compensatory mechanism preserving cardiac output during detrimental stimuli. Nevertheless, long-term stimuli incite chronic hypertrophy and may lead to heart failure. In this review, we analyze the recent literature regarding the role of ERK (extracellular sign...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gallo, Simona, Vitacolonna, Annapia, Bonzano, Alessandro, Comoglio, Paolo, Crepaldi, Tiziana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6539093/ https://www.ncbi.nlm.nih.gov/pubmed/31052420 http://dx.doi.org/10.3390/ijms20092164

Ejemplares similares

MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor
por: Gallo, Simona, et al.
Publicado: (2022)

NMDA Receptor and Its Emerging Role in Cancer
por: Gallo, Simona, et al.
Publicado: (2023)

HGF and MET: From Brain Development to Neurological Disorders
por: Desole, Claudia, et al.
Publicado: (2021)

The Long-Lasting Protective Effect of HGF in Cardiomyoblasts Exposed to Doxorubicin Requires a Positive Feed-Forward Loop Mediated by Erk1,2-Timp1-Stat3
por: Gallo, Simona, et al.
Publicado: (2020)

Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor
por: Desole, Claudia, et al.
Publicado: (2021)

Identification of novel circulating microRNAs in advanced heart failure by next‐generation sequencing
por: Galluzzo, Alessandro, et al.
Publicado: (2021)

The PSI Domain of the MET Oncogene Encodes a Functional Disulfide Isomerase Essential for the Maturation of the Receptor Precursor
por: Altintas, Dogus Murat, et al.
Publicado: (2022)

Activation of the MET receptor attenuates doxorubicin‐induced cardiotoxicity in vivo and in vitro
por: Gallo, Simona, et al.
Publicado: (2020)

The macrophage: a key player in the pathophysiology of peripheral neuropathies
por: Msheik, Zeina, et al.
Publicado: (2022)

Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4
por: Xiao, Zheng, et al.
Publicado: (2020)

Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
por: Modica, Chiara, et al.
Publicado: (2020)

Cytokines as Key Players in the Pathophysiology of Preeclampsia
por: Raghupathy, Raj
Publicado: (2013)

Neuraminidases—Key Players in the Inflammatory Response after Pathophysiological Cardiac Stress and Potential New Therapeutic Targets in Cardiac Disease
por: Heimerl, Maren, et al.
Publicado: (2022)

Mastitis in Autoimmune Diseases: Review of the Literature, Diagnostic Pathway, and Pathophysiological Key Players
por: Goulabchand, Radjiv, et al.
Publicado: (2020)

HGF/Met Axis in Heart Function and Cardioprotection
por: Gallo, Simona, et al.
Publicado: (2014)

Ezrin Is an Effector of Hepatocyte Growth Factor–mediated Migration and Morphogenesis in Epithelial Cells
por: Crepaldi, Tiziana, et al.
Publicado: (1997)

Arginase Signalling as a Key Player in Chronic Wound Pathophysiology and Healing
por: Szondi, Denis C., et al.
Publicado: (2021)

Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy
por: Cipolletta, Ersilia, et al.
Publicado: (2015)

Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress
por: Tusa, Ignazia, et al.
Publicado: (2023)

CircHIPK3: Key Player in Pathophysiology and Potential Diagnostic and Therapeutic Tool
por: Zhou, Jiang, et al.
Publicado: (2021)

The cardiac translational landscape reveals that micropeptides are new players involved in cardiomyocyte hypertrophy
por: Yan, Youchen, et al.
Publicado: (2021)

miRNAs as Key Players in the Management of Cutaneous Melanoma
por: Lorusso, Celeste, et al.
Publicado: (2020)

Signaling pathways in human osteoclasts differentiation: ERK1/2 as a key player
por: Pennanen, Paula, et al.
Publicado: (2021)

Editorial: Human microbiota: A key player in the etiology and pathophysiology of cardiovascular and metabolic diseases
por: Velmurugan, Ganesan, et al.
Publicado: (2022)

Exploring Key Genes and Pathways of Cardiac Hypertrophy Based on Bioinformatics
por: Zhang, Zhenzhen, et al.
Publicado: (2022)

Non-Coding RNA as Novel Players in the Pathophysiology of Schizophrenia
por: Gibbons, Andrew, et al.
Publicado: (2018)

A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart
por: Sala, Valentina, et al.
Publicado: (2016)

Editorial: Obesity, hyperglycemia, and pregnancy: from pathophysiology to clinical practice - volume II
por: Succurro, Elena, et al.
Publicado: (2023)

Molecular biomarkers in cardiac hypertrophy
por: Zhu, Liu, et al.
Publicado: (2019)

MicroRNAs in Cardiac Hypertrophy
por: Wehbe, Nadine, et al.
Publicado: (2019)

Impact of hyperthyroidism on cardiac hypertrophy
por: Barreto-Chaves, M L M, et al.
Publicado: (2020)

The Microenvironment of the Pathogenesis of Cardiac Hypertrophy
por: Bazgir, Farhad, et al.
Publicado: (2023)

Cardiomyocyte BRAF is a key signalling intermediate in cardiac hypertrophy in mice
por: Alharbi, Hajed O., et al.
Publicado: (2022)

A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone
por: Verschuren, Lars, et al.
Publicado: (2014)

ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
por: Salaroglio, Iris C., et al.
Publicado: (2019)

Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2010)

Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2009)

Rapamycin Inhibits Cardiac Hypertrophy by Promoting Autophagy via the MEK/ERK/Beclin-1 Pathway
por: Gu, Jun, et al.
Publicado: (2016)

Endothelial Cells and Mitochondria: Two Key Players in Liver Transplantation
por: Parente, Alessandro, et al.
Publicado: (2023)

Soluble adenylyl cyclase: A novel player in cardiac hypertrophy induced by isoprenaline or pressure overload
por: Schirmer, Ilona, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vtriu3viqnqrkqv846r0c9fc13